Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PM1022 in Advanced Tumors
NCT05867771Phase 2Unknown
- Sponsor
- Biotheus
- Start
- Apr 2022
- Primary completion
- Apr 2024
- Modality
- Bispecific Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of PM1022 in solid tumor (advanced stage), sponsored by Biotheus. Status: unknown.
02
Drugs
PM1022
03
Conditions
solid tumor (advanced stage)
Beyond the preview
Go deeper on NCT05867771.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05867771.